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Background: Biomarkers are useful tools in research and clinical practice where they are often used to detect and
monitor differences in the physiological state of an animal. The proteins IGF-1, IGFBP-3, GHR, CRP, SAA, Hp, IFN-α,
IFN-γ, TNF-α, IL-1β, IL-6, IL-10, and IL-18 have been proposed as potential biomarkers for monitoring growth in livestock.
The objective of this study was to determine whether hepatic gene expression of these proposed biomarkers is
associated with growth performance in nursery pigs. Herd information and growth parameters were collected for
168 piglets from 8 commercial farms in southern Ontario. From these pigs, a subset of liver tissue samples (n = 74)
was used for gene expression analysis of the proposed biomarkers. Multivariable linear regression methods were
used to determine whether genetic expression of the proposed biomarkers was associated with growth
performance in the nursery.
Results: Modelling the herd information and individual piglet traits in relation to growth performance revealed
that the weight at weaning and the age at weaning are significantly associated with nursery performance. Average
daily gain (ADG) was significantly associated with hepatic IGFBP-3 and GHR expression in the liver (P < 0.05), and
tended to be associated with hepatic IGF-1 expression (P = 0.071). Similarly, 9-week body weight was significantly
associated with hepatic expression of IGFBP-3 and GHR expression (P < 0.05), and tended to be associated with
hepatic expression of IGF-1 (P = 0.055).
Conclusion: The age and weight at which pigs are weaned is an important determinant for nursery performance.
Hepatic gene expression of IGF-1, IGFBP-3, and GHR can be useful biomarkers for monitoring growth performance
in nursery pigs.
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The insulin-like growth factor (IGF) system is important
for development and tissue growth in livestock species.
Insulin-like growth factor-1 (IGF-1) is primarily synthe-
sized by the liver and is crucial for stimulating cellular
proliferation and differentiation in brain, muscle, and
bone tissue [1]. The expression of IGF-1 is mediated by
growth hormone (GH), a peptide hormone released by
the anterior pituitary gland [2]. The binding of GH to
growth hormone receptors (GHR) in hepatic tissue in-
duces expression of IGF-1 [3]. IGF-1 expression is* Correspondence: afarzan@uoguelph.ca
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reproduction in any medium, provided the orassociated with increased body weight as demonstrated
by transgenic over-expression of IGF-1 in mice [4]. The
transportation and bioavailability of IGF-1 is facilitated
by IGF binding proteins (IGFBPs) which circulate in the
blood [5]. The most abundant is IGFBP-3 which binds
most circulating IGF-1 [6]. Experiments using a transgenic
mouse model have demonstrated that over-expression of
IGFBP-3 is associated with growth impediment [7]. In
pigs, previous research suggests that serum IGF-1 is posi-
tively associated with average daily gain (ADG) and serum
IGFBP-3 is negatively associated with ADG [8]. Additional
studies have demonstrated that the IGF system is import-
ant for postnatal maturation and the development of
desirable carcass traits [9-11]. Although these findings
demonstrate that the IGF system plays an important roleLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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in gene expression affect growth performance in pigs, and
whether these genes can be used as biomarkers to monitor
growth performance across different commercial farms.
There are previous studies which also suggest that
growth performance in pigs may be associated with
changes in serum concentrations of acute-phase proteins
(APP), including C-reactive protein (CRP), haptoglobin
(Hp), and serum amyloid A (SAA) [12-15]. It has been
proposed that Hp may be a suitable biomarker for moni-
toring production performance on commercial swine
farms [15]. Serum levels of certain cytokines, including
interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8
(IL-8), interleukin-18 (IL-18), and tumor necrosis factor-
α (TNF-α), have also been associated with body weight
in horses and in humans [16-20]. However, the useful-
ness of these APPs and cytokines as biomarkers for
monitoring the growth performance of pigs on commer-
cial swine farms has not been established. The objective
of this study was to investigate the association between
the hepatic gene expression of potential biomarkers, in-
cluding IGF-1, IGFBP-3, GHR, CRP, SAA, Hp, IFN-α,
IFN-γ, TNF-α, IL-1β, IL-6, IL-10, IL-18, and growth per-
formance in nursery pigs across diverse commercial
farm conditions. A secondary objective of this study was
to determine extraneous factors which may influence
growth performance in the nursery as such factors are
critical for assessing the association between potential
biomarkers and nursery performance.
Methods
Experimental design and sampling
The use of animals in this study was approved by the
Animal Care Committee at the University of Guelph.
Eight swine farms in southern Ontario were recruited to
participate in a collaborative field study. On each farm,
seven sows were randomly enrolled in the study and
three piglets (small, medium, and large size) were se-
lected from each sow at weaning and ear tagged. In total
168 piglets (21 piglets per farm) were included. All male
piglets recruited in this study were castrated. A ques-
tionnaire was administered and information about the
enrolled sows (farrowing date, parity, litter size, numbers
of live born, stillborn), farm management (pig flow,
number of gilts, sows, nursery pigs, and grower-finishers,
and type of farrowing room floor), health status (recent
diseases, mortality in different stage of production), vac-
cination, and in-feed drug use was collected. Piglets were
weighed at weaning and once again at 5 weeks post-
weaning. Fecal and blood samples were collected at wean-
ing, 2 weeks post-weaning, and 5 weeks post-weaning.
At 5 weeks post-weaning the piglets were transported
to the University of Guelph where they were euthanized.
Tissue samples collected immediately from the liver,intestinal lymph node, ileum, and spleen were placed
immediately into RNAlater and allowed to sit at 4°C for
24 h before being stored at −80°C. Samples were stored
at −80°C for no longer than 4 weeks before being proc-
essed for gene expression analysis. Separate portions of
the ileum and colon were collected and nasal swabs,
blood, and fecal samples were collected from each pig
prior to euthanasia.
Calculating growth performance
Growth performance was determined by assessing the
post-weaning ADG and the 9 week body weight (9-wk
BW) of each nursery piglet. ADG was calculated as the
difference between the weaning weight and the 5-wk
post-weaning weight, divided by the number of days be-
tween each weighing. Body weights were standardized to
9 weeks of age as there was considerable variation in
piglet age within each farm and between farms. Body
weights were standardized to 9 weeks of age as the mean
age at the second weighing was 59.5 d.
RNA Extraction
Seventy-four pigs from 4 representative farms with dif-
ferent health status and production parameters were
included for gene expression analysis. RNA was ex-
tracted from liver tissue using a Qiagen RNeasy Mini
Kit (Qiagen). Approximately 30 mg of liver tissue was
added to 600 μl of RLT buffer in a RNase-Free tube and
homogenized for 30–40 sec using a tissue homogenizer
(PowerGen 125, Fisher Scientific). RNA was then ex-
tracted from the homogenate as outlined by the manufac-
turer’s protocol without any modifications (Qiagen). The
concentration of the eluted RNA was determined using
the Thermo Scientific NanoDrop 8000 Spectrophotometer
(Fisher Scientific), and RNA was re-extracted from sam-
ples with signs of degradation or contamination.
All RNA samples were treated with an Amplification
Grade DNase I kit (Sigma-Aldrich) to remove any gen-
omic DNA. 24 μl of nucleic acid-free water, 3 μl of reac-
tion buffer, 3 μl of Amplification Grade DNase I, and
3 μg of total RNA (1 unit/μl) were added together and
centrifuged for 10 seconds to collect the reaction at the
bottom of the tube. The mixtures were incubated at
room temperature for 15 min. 3 μl of the Stop Solution
(50 mM EDTA) was added and the mixtures were incu-
bated at 70°C for 10 min. The mixtures were then
chilled on ice before being stored at −80°C.
The purity and concentration of RNA was reassessed
after DNase digestion using the Thermo Scientific Nano-
Drop 8000 Spectrophotometer (Fisher Scientific). The
integrity of all the RNA samples was assessed using the
Agilent 2100 Bioanalyzer (Agilent Technologies) before
and after DNase treatment to ensure there was no indi-
cation of degradation. The mean RNA Integrity Number
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peated as recommended by Fleige and Pfaffl [16].
Primer design and efficiency
Primer designs and efficiencies are listed in Table 1.
Primers for IL-1β, IL-10, IFN-α, and IFN-γ were previ-
ously designed by Collado-Romero et al. [17]. All other
primer sequences were designed and screened for hom-
ology using the NCBI Primer-BLAST program. The
cDNA sequences used to design the primers were ob-
tained from the GenBank database. Primers were designed
to span known exon-exon junctions. Primer efficiency and
the coefficient of determination (R2) were determined
using the StepOnePlus™ Real-Time PCR System (Applied
Biosystems).Table 1 Primers used for RT-qPCR of hepatic biomarkers
Gene symbol Gene name Accession numbera Primers (5′ –
IL1B Interleukin-1β NM_214055 F: GGCCGCCA
R: GGACCTCT
IL6 Interleukin-6 NM_214399 F: CCCTGAGG
R: CGTGGACG
IL10 Interleukin-10 L20001 F: CAGATGGG
R: ACAGGGC
IL18 Interleukin-18 NM_213997 F: GCTGCTGA
R: AAACACGG
IFNA Interferon-α AB257591 F: GACCTGCC
R: ATGGCTTG






CRP C-reactive protein NM_213844 F: TGCCCAGA
R: GGTCGGTA
HP Haptoglobin NM_214000 F: TGAATGTG
R: CGAGGTGA





















bDesigned by Collado-Romero et al. [17].Analysis of gene expression with RT-qPCR
Relative gene expression was assessed using a real time
quantitative polymerase chain reaction (RT-qPCR) assay.
The synthesis of cDNA and the RT-qPCR assay were
completed by the Advanced Analysis Centre’s Genomic
Facility at the University of Guelph. For synthesis of
cDNA, 1000 ng of total RNA was reverse transcribed
into cDNA using the High Capacity cDNA Reverse
Transcription kit (Applied Biosystems). A total reaction
volume of 20 μl was used for reverse transcription; 2 μl
of reverse transcript buffer, 0.8 μl (100 mM) dNTP, 2 μl
random priming oligonucleotides , 1 μl of MultiScribe™
Reverse Transcriptase (50 U/μl) (Applied Biosystems),
4.2 μl of nucleic acid-free water, and 10 μl (1000 ng) of




AGATATAACTGAb 59 70 0.991 100
GGGTATGGCTTTCb
CAAAAGGGAAAGA 60 212 0.998 95.2
GCATCAATCTCA
CGACTTGTTGb 57 219 0.993 91.7
AGAAATTGATGACb
ACCGGAAGACAA 60 192 0.996 95.3
CTTGATGTCCCT
TCAGATCCACAG 60 158 0.986 82.3
AGCCTTCTGGAC
TCAGTGAACTCATGAb 60 100 0.985 98.7
TTGGAACATAGTCTb
CTTCCTCCTGb 57 194 0.997 100
TTGACATTGGb
CAGACATGATCG 60 131 0.999 100
TAGACACGCAGG
AAGCAGTGTGCG 59 133 0.996 96
GGTTATGGTGGG
GATGCCAGAGAG 60 85 0.998 87.8
CTCCACTCCGTG
TGGCCCTGTGCTT 61 81 0.998 97.7
GCCCCACAGA
CATCCCCAACT 60 80 0.990 97.3
CCTGCCTTT
GGCCTCGTACTC 60 80 0.999 89.2
AGCCACACGATGA
AGCATCTCCTGACT 61 80 0.998 100
GGTCTCCCTAAGC
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cooled at 4°C.
GAPDH and RLP4 were evaluated as potential refer-
ence genes for the present study based on validation and
reliable performance in previous research [10,18-20].
The stability of these reference genes in the liver tissue
samples was measured using RT-qPCR and analyzed
using BestKeeper software [21]. The RT-qPCR cycle
quantification (Cq) values of GAPDH and RLP4 had
standard deviations of 0.34 and 0.49, respectively.
GAPDH was chosen as the only endogenous reference
gene to be used for internal normalization of gene ex-
pression data in this study due to its very low variability
(Cq = 18.17 ± 0.34) for the present samples and its reli-
able performance as a sole reference gene in previous
studies [10,20].
A single StepOnePlus™ Real-Time PCR System (Applied
Biosystems) was used for all RT-qPCR assays in this study.
The RT-qPCR assay was completed using duplicates of
each sample. Each 20 μl reaction consisted of 7.5 μl of 2×
PerfeCta SYBR Green FastMix ROX (Quanta BioScience),
5 μl of template cDNA, 1.9 μl of molecular grade water,
and 0.6 μl of primer. The final primer concentration in
each reaction was 200 nM. The RT-qPCR assay conditions
were 95°C for 30 s followed by 40 cycles of 95°C for 15 s
and 60°C for 30 s. A melting curve was performed to con-
firm specificity of the amplicon.
Statistical analysis
Linear regression methods were used to model production
parameters and gene expression (ΔCq) in relation to
growth performance. First, the Cq values of each bio-
marker were normalized using the Cq values of the en-
dogenous reference gene GAPDH as described by the
following equation:
ΔCq ¼ Cqof target gene
 
– Cqof reference gene
 
ð1Þ
The normalized ΔCq values already exist as the log
transformed product of the expression ratios that are
conventionally calculated using the 2-ΔΔCt method [22],
thereby fulfilling the assumption of linearity. The linear-
ity of the ΔCq data was confirmed by assessing a
smoothed locally weighted scatterplot. The ΔCq values
were modelled as the magnitude of gene expression for
each target gene.
One multivariable random-effect generalized least
squares (GLS) model and two multivariable fixed-effect
least squares dummy variable (LSDV) models were cre-
ated in STATA 10.0 (Stata Corporation, College Station,
TX). The GLS model was designed to evaluate the asso-
ciation of production characteristics with 9-wk BW
across the 8 farms. The two LSDV models were designedto determine the association of biomarker expression
with ADG and 9-wk BW across 4 farms. Extraneous var-
iables that were used for model building include the
farm, parity of the sow, stillbirths per litter, live births
per litter, sex of the piglet, age at weaning, weight at
weaning, and disease status. Each model was manually
designed using a parsimonious approach. All variables
were first screened individually with univariable linear
regression. Variables with a liberal p-value of ≤0.20 were
included in the initial model. All variables regardless of
inclusion were evaluated for confounding. A variable
was determined to be a confounder if its inclusion in the
model changed the coefficient of any predictor by ≥20%.
Two-way interactions were generated for all variables in
the initial model and interactions were retained in the
model if they were statistically significant (P < 0.05). Any
variable from the initial model was only retained in the
final model if it was statistically significant (P < 0.05), if
the variable behaved as a confounder, or if the variable
was a component of a statistically significant interaction
term. If two independent variables presented colinearity
(R2 > 0.8) then the less significant variable was excluded.
Clustering at the farm level was accounted for by model-
ling each farm as a random-effect in the GLS model and
as a fixed-effect in the LSDV models. Homoskedasticity
and normal distribution of standardized residuals was
assessed graphically for the GLS model. The assump-
tions of constant variance and normal distribution of
standardized residuals was evaluated for each LSDV
model using the Cook-Weisberg test and the Shapiro-
Wilk test, respectively. Diagnostic analysis revealed no
outliers or extremely influential observations. However,
observations for two pigs were excluded from the model
due to missing data. Effects with a P < 0.05 were consid-
ered statistically significant and non-significant effects
with a P < 0.10 were considered to be suggestive of an
association. All descriptive statistics are reported as the
mean ± standard deviation.
Results
The mean performance parameters for each farm are
presented in Table 2. The average weight at 5-wk post-
weaning (59.5 ± 5.5 d) was 19.6 ± 4.3 kg. From weaning
to 5-wk post-weaning, a total mortality and culling rate
of 2.4% (4/168) was observed. Table 3 summarizes the
sow characteristics of each farm.
In the first model, sow parity, live births per litter, still-
births per litter, sex, age at weaning, and the weight at
weaning were used as the independent variables to de-
termine an association with 9-wk BW. There were no
additional confounding effects or significant interaction
terms detected. The final model revealed that only the
weight at weaning and the age at weaning were signifi-
cantly associated with 9-wk BW (Table 4). This model






9-wk BW (kg) ADG (g/day)
1a 26.7 ± 1.19 6.19 ± 1.54 21.9 ± 3.24 399 ± 62.4
2a 22.7 ± 3.36 6.41 ± 1.70 17.4 ± 4.31 267 ± 77.0
3a 34.4 ± 7.16 8.93 ± 2.00 21.0 ± 3.47 334 ± 72.4
4 28.3 ± 1.06 6.71 ± 1.88 22.2 ± 4.52 306 ± 65.0
5 30.9 ± 2.92 7.95 ± 1.81 20.2 ± 4.32 360 ± 97.1
6 18.7 ± 0.49 7.04 ± 1.51 22.6 ± 3.01 340 ± 47.5
7 26.1 ± 0.74 8.19 ± 1.82 23.0 ± 4.70 387 ± 143.9
8a 22.4 ± 1.96 5.81 ± 1.30 17.9 ± 3.20 296 ± 55.5
Mean 26.4 ± 5.59 7.16 ± 1.96 20.7 ± 4.31 336 ± 83.2
BW body weightm, ADG post-weaning average daily gain.
aGene expression analysis was performed on liver tissue from the piglets
originating from these farms.
Table 4 Characteristics associated with the weight of pigs
at 9 weeks of age (model 1)
Variable Coefficienta SE 95% CI P value
Weight at weaning 1.670 0.128 1.419, 1.920 <0.001
Age at weaning −0.226 0.069 −0.361, −0.090 0.001
Sex 0.524 0.424 −0.307, 1.356 0.217
Parity of sow 0.072 0.097 −0.117, 0.262 0.455
Stillbirths per litter 0.290 0.248 −0.197, 0.777 0.243
Live births per litter −0.102 0.093 −0.285, 0.081 0.274
SE standard error, CI confidence interval.
aThe predicted change in body weight (kg) at 9 weeks of age if the
corresponding variable is increased by one unit (ie. the model predicts a
decrease of 0.226 kg in body weight at 9 weeks of age if a pig is weaned one
day later).
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herd. The intraclass correlation coefficient (ICC) was
0.668 based on the herd-level and animal-level variance
for the 8 farms.
Multivariable analysis revealed ADG was not signifi-
cantly associated with hepatic gene expression of CRP,
SAA, Hp, IFN-α, IFN-γ, TNF-α, IL-1β, IL-6, IL-10, and
IL-18 in the liver (P > 0.05), and none of these variables
were retained in the final model. The effects of IGFBP-3
expression (P = 0.016) and GHR expression (P = 0.009)
on ADG were statistically significant and the effect of
IGF-1 expression (P = 0.071) was suggestive (Table 5).
The model was able to explain 52.9% of the variation in
post-weaning ADG. The weight at weaning was retained
in the model because it had a confounding effect. All
two-way interactions were not significant and thus ex-
cluded from the final model.
Expression of CRP, SAA, Hp, IFN-α, IFN-γ, TNF-α,
IL-1β, IL-6, IL-10, and IL-18 in the liver did not affect








1 650 2.3 ± 1.9 12.6 ± 2.8 0.9 ± 0.6
2 500 3.6 ± 2.3 11.4 ± 2.8 1.1 ± 1.0
3 1000 2.3 ± 3.2 13.9 ± 1.3 0.4 ± 1.4
4 240 2.3 ± 1.2 11.0 ± 0.5 0.6 ± 0.5
5 123 4.9 ± 2.2 12.3 ± 2.0 1.4 ± 1.0
6 650 3.1 ± 1.9 13.4 ± 1.7 1.0 ± 1.1
7 850 3.6 ± 2.2 11.3 ± 2.7 1.0 ± 0.8
8 670 4.1 ± 2.9 12.9 ± 3.2 0.1 ± 0.4
Mean 585 3.3 ± 2.43 12.3 ± 2.46 0.8 ± 1.0
abased on the seven randomly selected sows per farm used in this study.excluded from the final model. However, the effects of
IGFBP-3 expression (P = 0.012) and GHR expression
(0.016) were significantly associated with 9-wk BW. The
effect of IGF-1 expression (P = 0.055) was suggestive of
an association (Table 6). The model was able to explain
69.4% of the variation in the 9-wk BW. The weaning age
and the weight at weaning were retained in the model
because both variables had a confounding effect. All
two-way interactions were excluded from the model as
none were statistically significant.
Discussion
The weight at weaning and the age at weaning both con-
tributed significantly to growth performance in nursery
pigs. The weight at weaning was positively associated with
body weight during the nursery period which is consistent
with results from previous studies [23-25]. Additional re-
search has demonstrated that pigs with higher weaning
weights reach market weight 9–15 days earlier [23,26].
These results support the importance of pre-weaning
interventions that improve weight at weaning and sub-
sequent performance in the nursery.
Growth performance was negatively associated with
age at weaning which implies that pigs weaned at an
earlier age will reach a greater body weight during the
nursery stage. This finding is in agreement with previous
research which indicates that late weaning is disadvanta-
geous for post-weaning growth performance [24]. Re-
search by Main et al. determined that weaning at 21.5 d is
optimal for nursery performance in multisite productionTable 5 Predicted change in ADG given a 2-fold increase
in gene expression (model 2)
Gene Change in ADG (g) SE 95% CI P value
IGF-1 12.85 6.990 −1.11, 26.82 0.071
IGFBP-3 −33.75 13.65 −61.03, –6.48 0.016
GHR 41.76 15.57 10.65, 72.87 0.009
ADG post-weaning average daily gain, SE standard error, CI confidence interval.
Table 6 Predicted change in 9-wk BW given a 2-fold
increase in gene expression (model 3)
Gene Change in 9-wk BW (kg) SE 95% CI P value
IGF-1 0.547 0.280 −0.012, 1.105 0.055
IGFBP-3 −1.409 0.545 −2.497, –0.320 0.012
GHR 1.580 0.638 0.305, 2.854 0.016
BW body weight, SE standard error, CI confidence interval.
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were >21.5 d old at weaning which is indicative of the
negative association observed between weaning age and
post-weaning growth performance.
The sex of the piglet was not associated with growth
performance in the nursery. These findings consistently
agree with previous research [23,24]. Growth performance
of gilts and barrows appears to be significantly different
only during the grower-finisher phase of production
[8,23]. Paredes et al. demonstrated that sex can be signifi-
cantly associated with nursery performance in different
data sets although the authors attributed this consequence
to differences in the proportion of intact males [25]. In the
present study, all male piglets had been castrated prior to
weaning.
Litter characteristics were not associated with nursery
growth performance. The parity of the sow, stillbirths
per litter, and live births per litter showed no effect on
9-wk BW. There are conflicting reports of the effects of
sow parity on post-weaning growth performance. A
study by Smith et al. suggests that piglets born to prim-
iparous sows have a growth disadvantage compared to
higher parity sows [28]. However, the authors noted that
the mean post-weaning weights varied greatly among
parties and there was no discernible pattern of growth
performance. Other researchers have concluded that
sow party does not influence growth performance at the
nursery stage [25]. In addition, previous findings have
demonstrated that the number of live births per litter is
not associated with post-weaning growth performance
[25], although the number of live births does appear to
be associated with birth weight [29]. One reason for lack
of association between sow characteristics and growth
performance in this study may have resulted from select-
ing three piglets of small, medium, and large size from
each sow.
Increased expression of IGF-1 in the liver showed a
tendency to be positively associated with ADG and 9-wk
BW. This is consistent with other studies which have de-
termined that serum IGF-1 concentration is positively
associated with growth in pigs and other animals [8,30].
Furthermore, over-expression of IGF-1 at 1.5-fold the
normal levels in transgenic mice resulted in a 30% in-
crease in body weight [4]. In this study, a smaller effect
was observed in pigs with the model predicting that a 2-fold increase in IGF-1 would result in a 2.6% increase in
body weight at 9 weeks of age for the average nursery
pig. The statistical significance of the association be-
tween IGF-1 and growth may have been undermined by
the large variation in IGF-1 RNA levels. The variation in
hepatic IGF-1 expression is likely due to the natural vari-
ability observed during this stage of development [1,30].
Additionally, differences in production management,
feed composition, and antimicrobial usage may have
contributed to the large variation in hepatic IGF-1 ex-
pression [31]. It is likely that differences in breed and
sex across farms were not a factor in variation as previ-
ous studies have demonstrated that IGF-1 levels are not
significantly different between breeds [10,32] or between
barrows and gilts [30]. Expression of IGF-1 is likely
more useful as a growth-associated biomarker for com-
paring pigs that are raised in the same herd under the
same conditions.
IGFBP-3 expression in the liver was negatively associ-
ated with ADG and 9-wk BW. The model designed in
this experiment predicted that a 2-fold increase in
IGFBP-3 expression would reduce 9-wk BW by 6.8% in
the average nursery pig. Contrary to the results of our
findings, previous research by Owens et al. showed a
weak positive correlation between serum IGFBP-3 con-
centration and ADG [30]. However, other research has
been demonstrated that IGFBP-3 is expressed significantly
less in gilts bred for enhanced growth performance com-
pared to gilts with diminished growth performance [8],
and that hepatic expression of IGFBP-3 is higher in slow-
growing breeds than in fast-growing breeds of pigs [10].
Further research using transgenic mice found that a 4.9-
7.7-fold increase in IGFBP-3 expression resulted in a 10%
reduction in birth weight, moderate post-natal growth re-
tardation, and reduced organ weight [7]. Over-expression
of IGFBP-3 in transgenic mice also resulted in a 1.9-2.8-
fold increase in circulating IGF-1 levels [7], a finding that
can be explained by the concomitant mechanisms that
regulate both IGF-1 and IGFBP-3 expression [33,34]. It is
likely that neglecting to account for IGF-1 levels during
analysis lead Owens et al. to discover a weak positive asso-
ciation between IGFBP-3 and growth performance [30].
Re-modelling the data from our study without IGF-1 con-
firmed that IGF-1 does have a major confounding effect
on the IGFBP-3 coefficient. Overall, the significant nega-
tive association between IGFBP-3 and growth perform-
ance found in the present study is consistent with findings
in other studies [7,8,10].
Expression of GHR in the liver was positively associated
with growth performance in nursery pigs. A 2-fold in-
crease in GHR expression appeared to have the greatest
effect on the magnitude of growth compared to the same
increase in IGF-1 and IGFBP-3 expression. A transgenic
experiment with mice demonstrated that deletion of the
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substantial reduction in body weight [35]. These findings
are consistent with the results presented in this paper.
Further studies have demonstrated that in vitro GHR ex-
pression of swine hepatocytes is significantly influenced by
glucose and amino acid concentrations [36], and in vivo
experiments with pigs indicate that dietary protein con-
centration is positively associated with GHR expression in
the liver, skeletal muscle, and adipose tissue [37]. In light
of the results from the present study, assessing expression
of GHR may be useful for evaluating the effects of differ-
ent dietary regiments on growth performance at the mo-
lecular level.
ADG and 9-wk BW were not associated with hepatic
expression of the APPs assessed in this study. A previous
experiment by Saco et al. demonstrated that Hp is a suit-
able biomarker for assessing the effects of an immuno-
modulating feed additive on production parameters [15].
However, Saco et al. were unable to exclusively identify
an association between Hp and growth performance
[15]. Additional research by Pineiro et al. demonstrated
differential serum concentrations of CRP and Hp be-
tween two groups of pigs subjected to different feeding
regiments [14]. Although the ADG was significantly dif-
ferent between groups, Pineiro et al. attributed the dif-
ferences in APP levels to stress caused by disorderly
feeding [14]. In this study it is likely that no significant
association was found between APP expression and
growth performance because APP levels are influenced
considerably by pathogen colonization and stress [14,38];
two factors which are not necessarily indicative of growth
performance. The results of the present study indicate that
CRP, Hp, and SAA are not suitable biomarkers for evalu-
ating the production performance of nursery pigs on com-
mercial farms.
The expression of IFN-α, IFN-γ, TNF-α, IL-1β, IL-6, IL-
10, and IL-18 in the liver was not significantly associated
with growth performance in nursery pigs. Earlier studies
have demonstrated that body weight is significantly associ-
ated with circulating levels of IL-6, IL-8, IL-18, and TNF-
α in humans [39,40], and differential expression of IL-1,
IL-6, and TNF-α in horses [41]. The lack of association
between body weight and hepatic cytokine expression ob-
served in this study is likely due to previous findings
which indicate that excess adipose tissue is the primary
source of increased levels of circulating cytokines [42-44].
Monitoring adipose-associated cytokines may be useful
for evaluating obesity in other species. Overall, cytokine
expression in the liver is unsatisfactory for monitoring
growth parameters in nursery pigs, although adipose or
serum levels of these cytokines may still prove to be useful
biomarkers to evaluate growth performance.
One of the limitations of this study was the lack of
dietary information for the swine herds. However, diet isuniform on each farm and farm-level clustering was
accounted for in each regression model during the statis-
tical analysis. Furthermore, it may be argued that diet acts
as an intervening variable which can introduce consider-
able variation into the data but would not need to be con-
trolled for the results to be valid.
Measuring the hepatic expression of IGF-1, IGFBP-3,
and GHR can be useful biomarkers for evaluating the
growth performance of nursery pigs. It is likely that sero-
logical levels of IGF-1, IGFBP-3, and GHR are representa-
tive of the changes in liver expression levels, however
further research is needed to confirm this assumption.
The advantages of evaluating gene expression is that it al-
lows for the determination of growth-associated biological
activity in specific tissues and it demonstrates that tran-
scriptional diversity is related to overall growth perform-
ance. Hence, the results of this study should direct future
research to explore whether any polymorphisms in growth
factor genes (IGF1, IGFBP3, GHR), or accessory genes
such as proteases, are associated with transcriptional di-
versity and indicative of growth performance in pigs.
Identifying polymorphisms related to growth factor ex-
pression may improve the selection of genetic lineages
for enhanced production performance. Quantifying IGF-1,
IGFBP-3, and GHR may also be beneficial in research and
experimental settings where they may be used, in addition
to conventional methods, to assess interventions, treat-
ments, or clinical pathologies in relation to growth per-
formance of nursery pigs. Future research should focus on
whether RNA and serum levels of IGF-1, IGFBP-3, and
GHR are indicative of growth performance at other phases
of swine production and whether biomarker expression
during the nursery phase can predict performance in later
phases of production.Conclusion
Overall, IGFBP-3 and GHR expression in the liver was
significantly associated with growth performance across
multiple swine production systems despite variation in
operating procedures. IGF-1 expression had a tendency
to be associated with the measured growth parameters
but the large variation reduced its statistical significance
in this study. Nevertheless, IGF-1 is likely a useful bio-
marker of growth performance for comparing pigs from
the same herd. IGFBP-3 and GHR appear to be suitable
biomarkers for evaluating growth performance in nur-
sery pigs, either in a controlled experimental setting or
in population-based studies involving multiple swine
herds with varying management practices. Hepatic ex-
pression of CRP, Hp, SAA, IFN-α, IFN-γ, TNF-α, IL-1β,
IL-6, IL-10, and IL-18 was not associated with the
growth parameters in this study and appear to be inad-
equate for monitoring growth in pigs.
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